Daiichi Sankyo announced that it has opened a new affiliate for its oncology business in Athens, Greece. The establishment highlights the company&r...
Funds to support Phase Ib clinical trial of HRX-215 in the US and an international multicenter Phase IIa clinical trial in liver regeneration Elias Pa...
Roche announced that it has received the CE Mark for its Accu-Chek® SmartGuide continuous glucose monitoring (CGM) solution. This signifi...
£90m ($114m) series A co-led by new leading life science investors Novo Holdings and Abingworth Additional new investors British Patient Capital...
Synsight provides Iktos with an exclusive worldwide license to INSERM’s patented technology enabling high performance AI-driven in cellulo screen...
Global biotechnology leader CSL Behring announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...
Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...
Hofseth BioCare ASA ("HBC" or the "Company"), a global leader in marine lipid and peptide research, announces the decision to transfer its eosinoph...
Valneva SE , a specialty vaccine company, today announced that the European Commission (EC) has granted marketing authorization in Europe for Val...
Dawn Health, the digital health company pioneering patient-first innovation, has announced they are working with leading global pharmaceutical company, M...
The World Health Organization (WHO) has awarded Roche's human papillomavirus (HPV) test prequalification designations for use on the cobas 5800 System ...
Merck, a leading science and technology company, is proud to announce the celebration of its 100th anniversary in Spain. Since opening our first commercial...
Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...
ANEW to explore therapeutics and specialty diagnostics utilizing the s-KL protein and will pursue other medical product development and commercial oppo...
© 2025 Biopharma Boardroom. All Rights Reserved.
